Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

Follistatin 344 research

6 articles to explore, with links to 8 original sources.

About Follistatin 344

Follistatin 344 is a precursor-associated form used in laboratory studies of activin and myostatin-related signaling.

Understand the science

  • How to read the posted Duchenne results

    Follistatin is a much larger protein. FST344 is the name of the longer precursor, and it also appears in the name of an investigational gene transfer intervention studied in Duchenne muscular dystrophy. The results posted in 2020 offer a separate clinical observation from the earlier Becker study.

    2 sources (2020, 2026)

Explore study findings

  • What a 2026 mouse study found about artery plaques

    Follistatin 344 is the longer precursor of a larger protein, follistatin. Cells process that precursor into the mature form called FST315. In July 2026, investigators reported using an FST344 gene transfer approach to study how follistatin affects the development of artery plaques in mice.

    2 sources (2026)

  • What a recent study record says about follistatin and age-related muscle loss

    Follistatin is a larger protein, and FST344 refers to the longer precursor that gives rise to the mature FST315 form. A 2026 trial registration explores an investigational gene therapy involving human follistatin in adults with age-related loss of muscle.

    3 sources (2014, 2026)

  • What six participants could reveal about Becker muscular dystrophy

    Follistatin is a larger protein that can bind activin and myostatin. Follistatin 344 is a precursor designation. In an older clinical study, first published online in 2014, investigators used an investigational FST344 gene transfer approach in people with Becker muscular dystrophy.

    1 source (2014)

Check methods and identity

  • What analytical researchers found behind the follistatin 344 label

    Follistatin 344 is the precursor designation for a larger protein that matures into FST315. An older analytical study investigated what researchers could actually detect in products labeled follistatin 344. The product name was a starting point for the analysis.

    3 sources (2019–2026)

Interpret the evidence

  • Why a comparison group matters in inclusion body myositis

    Follistatin is a larger binding protein. FST344 denotes the precursor of the mature FST315 form. A 2017 study used an investigational FST344 gene transfer approach in people with sporadic inclusion body myositis and compared their walking results with those of people from the same clinic.

    2 sources (2017, 2026)

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.